Elevation of CD74 is associated with a number of human cancers, including clear cell renal cell carcinoma (ccRCC). To understand the role of CD74 in the oncogenic process of ccRCC, we ectopically expressed CD74 in human embryonic kidney 293 cells (HEK/CD74) and evaluated its oncogenic potential. Through overexpression of CD74 in HEK293 and Caki -2 cells and down-regulation of CD74 in Caki-1 cells, we show that vascular endothelial growth factor-D (VEGF-D) expression is modified accordingly. A significant, positive correlation between CD74 and VEGF-D is found in human ccRCC tissues (Pearson's correlation, r = 0.65, p < 0.001). In HEK / CD74 xenograft mice, CD74 significantly induced the formation of tumor masses, increased tumor-induced angi...
Background: Vascular endothelial growth inhibitor (VEGI) is a member of the tumor necrosis factor su...
Metastasis to local lymph nodes via the lymphatic vessels is a common step in the spread of solid tu...
Background: Clear cell renal cell carcinoma (ccRCC), the most aggressive renal cancer, is characteri...
Purpose: While macrophage migration inhibitory factor (MIF) has been extensively studied in the cont...
Seventy-five percent of all cases of renal cell carcinoma have clear cell histology (CCRCC). In CCR...
Vascular endothelial growth factor (VEGF) plays a crucial role in tumor angiogenesis. VEGF expressio...
Vascular endothelial growth inhibitor (VEGI) has been associated with tumor-related vasculature in c...
Renal cell carcinoma, a malignant tumor originating from the renal tubular epithelium, accounts for ...
Aims: To evaluate the role and expression of vascular endothelial growth inhibitor isoform 174 (VEGI...
International audienceBACKGROUND.: Tumor angiogenesis is a dynamic process that plays a major role i...
The presence of lymphatic metastases is a strong indicator for poor prognosis in patients with ducta...
Vascular endothelial growth inhibitor (VEGI) is a recently identified antiangiogenic cytokine that b...
Abstract Kidney cancer, especially clear cell renal cell carcinoma (ccRCC), is one of the representa...
PURPOSE: CD70, a member of the TNF ligand superfamily, has been shown frequently overexpressed in cl...
AbstractVascular endothelial growth factor D (VEGF-D) promotes the lymph node metastasis of cancer b...
Background: Vascular endothelial growth inhibitor (VEGI) is a member of the tumor necrosis factor su...
Metastasis to local lymph nodes via the lymphatic vessels is a common step in the spread of solid tu...
Background: Clear cell renal cell carcinoma (ccRCC), the most aggressive renal cancer, is characteri...
Purpose: While macrophage migration inhibitory factor (MIF) has been extensively studied in the cont...
Seventy-five percent of all cases of renal cell carcinoma have clear cell histology (CCRCC). In CCR...
Vascular endothelial growth factor (VEGF) plays a crucial role in tumor angiogenesis. VEGF expressio...
Vascular endothelial growth inhibitor (VEGI) has been associated with tumor-related vasculature in c...
Renal cell carcinoma, a malignant tumor originating from the renal tubular epithelium, accounts for ...
Aims: To evaluate the role and expression of vascular endothelial growth inhibitor isoform 174 (VEGI...
International audienceBACKGROUND.: Tumor angiogenesis is a dynamic process that plays a major role i...
The presence of lymphatic metastases is a strong indicator for poor prognosis in patients with ducta...
Vascular endothelial growth inhibitor (VEGI) is a recently identified antiangiogenic cytokine that b...
Abstract Kidney cancer, especially clear cell renal cell carcinoma (ccRCC), is one of the representa...
PURPOSE: CD70, a member of the TNF ligand superfamily, has been shown frequently overexpressed in cl...
AbstractVascular endothelial growth factor D (VEGF-D) promotes the lymph node metastasis of cancer b...
Background: Vascular endothelial growth inhibitor (VEGI) is a member of the tumor necrosis factor su...
Metastasis to local lymph nodes via the lymphatic vessels is a common step in the spread of solid tu...
Background: Clear cell renal cell carcinoma (ccRCC), the most aggressive renal cancer, is characteri...